-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Peripheral T-cell lymphoma (PTCL) is a rare, heterogeneous malignancy that relapses with poor patient outcomes
Peripheral T-cell lymphoma (PTCL) is a rare, heterogeneous malignancy that relapses with poor patient outcomes
Hypomethylating agents (HMAs) are a class of epigenetic antineoplastic drugs that have been previously shown to have a role in PTCL, along with genetic mutations shared with myelodysplastic syndromes (MDS)
In this phase II, single-arm trial, patients with PTCL received guadecitabine on days 1-5 of a 28-day treatment cycle
In this phase II, single-arm trial, patients with PTCL received guadecitabine on days 1-5 of a 28-day treatment cycle
Wong, J.
https://doi.
org/10.
1038/s41375-022-01571-8
Leave a comment here